The Massachusetts Alzheimer's Disease Research Center (ADRC) is a multi- institutional consortium composed of Harvard affiliated facilities including the Massachusetts General Hospital, Beth Israel Hospital, McLean Hospital, Children's Hospital, Brigham & Women's Hospital, and the Harvard Division on Aging; the Massachusetts Institute of Technology; and the University of Massachusetts Medical Center. Each institution supports research in AD and has a proven track record of excellence. We have joined together in order to amplify existing research and to accelerate the pace of understanding and treating AD. The ADRC consortium provides a framework for pooling technological resources and gaining sufficient collaborative manpower, patient enrollment, and autopsy material to conduct the wide range of studies proposed. The overall broad goals of the Massachusetts ADRC are identical to those first proposed five years ago: to enhance currently funded research, to propose new experiments in fields of neuroscience related to dementia, and to catalyze research training and information transfer related to AD. In order to accomplish these goals, we will retain four Core facilities that were established during the initial grant cycle. The Administrative Core is responsible for organizing and maintaining the Center. The Clinical Core examines and diagnoses patients with AD and related dementias; enrolls them into ADRC; and refers them for participation in specific research projects. The Neuropathology Core establishes diagnoses on all brains submitted to the Tissue Resource Center; stores tissue for morphometric, neurochemical, and immunocytochemical studies; and distributes brain tissue to ADRC investigators. The Research Training and Information Transfer Core has developed programs to train the future leaders in the academic fields relevant to aging and dementia; the Core promotes exchange of information among ADRC professionals and with the lay community. The overriding mission of the ADRC is to stimulate and support projects plus eight pilot projects whose broad themes are to understand the etiology and behavioral alterations, and to develop effective modes of treatment for AD. The Core facilities provide resources for the research projects and are in turn sustained by them. Overall, the framework of the ADRC increased the involvement of Massachusetts researchers in AD and amplifies their productivity.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005134-08
Application #
3104749
Study Section
Aging Review Committee (AGE)
Project Start
1984-09-28
Project End
1994-03-31
Budget Start
1991-04-01
Budget End
1992-03-31
Support Year
8
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Woerman, Amanda L; Kazmi, Sabeen A; Patel, Smita et al. (2018) MSA prions exhibit remarkable stability and resistance to inactivation. Acta Neuropathol 135:49-63
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Bennett, Rachel E; Bryant, Annie; Hu, Miwei et al. (2018) Partial reduction of microglia does not affect tau pathology in aged mice. J Neuroinflammation 15:311
Arnold, Steven E; Betensky, Rebecca A (2018) Multicrossover Randomized Controlled Trial Designs in Alzheimer Disease. Ann Neurol 84:168-175
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Donovan, Nancy J; Locascio, Joseph J; Marshall, Gad A et al. (2018) Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults. Am J Psychiatry 175:530-537
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10-17
Quiroz, Yakeel T; Sperling, Reisa A; Norton, Daniel J et al. (2018) Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease. JAMA Neurol 75:548-556
Wilmoth, Kristin; LoBue, Christian; Clem, Matthew A et al. (2018) Consistency of traumatic brain injury reporting in older adults with and without cognitive impairment. Clin Neuropsychol 32:524-529

Showing the most recent 10 out of 966 publications